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E-mail address: Director@greaterhealth.org (J.A. DBackground: An evaluation of the sustainability of lifestyle changes was undertaken for participants com-
pleting a 12 month diabetes prevention program. This second part of the study also tested whether reg-
ular structured telephone calls could be effective in maintaining lifestyle changes.
Methods: Originally, 237 participants completed a 12 month group-based lifestyle intervention study.
They were aged 40–75 years, with a moderate to high risk of developing type 2 diabetes. Participants
were then randomised to telephone support (n = 107) or self-care only (n = 98) for 18 months, and re-
assessed using anthropometric, clinical, psychological and general health measures.
Results: A total of 164 participants (85 telephone support and 79 self-care only) completed the follow-up.
Changes between 12 and 30 months for the telephone support group were not signiﬁcantly different from
those found in the self-care only group. Beneﬁcial lifestyle changes achieved by participants were gener-
ally sustained after the diabetes prevention program, with the exception of fasting plasma glucose and
some psychological measures.
Conclusions: Positive outcomes achieved at 12 months were generally maintained after a further
18 months. Telephone support did not appear to produce additional beneﬁts.
 2010 International Journal of Diabetes Mellitus. Published by Elsevier Ltd.
Open access under CC BY-NC-ND license.1. Introduction
Type 2 Diabetes Mellitus (T2DM) is a major current health con-
cern worldwide [1,2]. The risk of developing T2DM is attributable
to both environmental and genetic factors [1], but the recent in-
crease in incidence seems to be mainly due to lifestyle factors, such
as dietary habits and lack of physical activity [3]. In 2004–2005,
about 700,000 Australians, or 3.6% of the population [4], were diag-
nosed with diabetes. About half of those who have diabetes are not
aware of their condition [5]. Of those with diabetes, around 83%
have type 2 (non-insulin dependent) diabetes [4]. It is estimated
that about 10.6% of Australians may have pre-diabetes or impaired
glucose tolerance [5], which is an early indicator for developing
diabetes (about one in three will go on to develop type 2 diabetes).
In 2004–2006, the Greater Green Triangle University Depart-
ment of Rural Health (GGT UDRH) developed a diabetes prevention
program (GGT DPP) for use in Australian primary health careellitus. Published by Elsevier Ltd.
angle University Department
. Box 423, Warrnambool, VIC
) 3 5563 3144.
unbar).
Osettings among English speaking groups [6]. The study provided
evidence that a type 2 diabetes prevention program using lifestyle
intervention is feasible in primary health care settings in Australia.
Results at 12 months included a mean weight reduction of 2.52 kg
and waist circumference by 4.17 cm, and an imputed risk reduc-
tion for T2DM of 40%. There was also a reduction in fasting and
2-h glucose values.
The GGT DPP was based on the Finnish Diabetes Prevention
Study (DPS) clinical trial [7] and the Good Ageing in Lahti Region
(GOAL) Lifestyle Implementation Trial [8] which was conducted
in a primary health care setting. Both of these interventions used
a lifestyle behaviour change approach for those at high risk. The
Finnish DPS showed a 58% relative risk reduction of T2DM after a
mean intervention period of 3.2 years [9]. The corresponding ﬁgure
at a median of seven years total follow-up was 43% [10]. The GOAL
Lifestyle Implementation Trial also reported sustainable results at
3 years [11].
Components of an ideal ongoing program to sustain lifestyle
changes achieved are yet to be determined. Recent studies evaluat-
ing use of the telephone as a primary method for delivering life-
style and chronic disease management interventions have shown
promising results [12]. The telephone has considerable andpen access under CC BY-NC-ND license.
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not limited by geographical barriers, and is being increasingly
adopted by large government and non-government organisations
with the capacity to deliver large-scale interventions.
The hypotheses in this study were: (1) that gains achieved at
12 months would be sustained at 30 months and (2) that a contin-
uing telephone support program with group facilitators would re-
sult in better maintenance of the measured outcomes 18 months
after completing the original 12 month GGT DPP intervention.2. Materials and methods
2.1. Design and recruitment of main intervention
The GGT DPP was conducted in Victoria and South Australia in
2004–2006, using primary health care as a setting to reduce the
progression to T2DM [6]. The Finnish Diabetes Risk Score (FIND-
RISC) tool [13] was used in general practice in three regions to
identify patients at high risk of developing T2DM. On this scale,
scores range from 0 to 26. A score of P12 predicts the develop-
ment of T2DM in more than one in six individuals within 10 years.
A minimum score of 12 was the main criterion for recruitment. The
recruits were given an oral glucose tolerance test, and those who
were found to already have diabetes were referred for treatment
to their family doctors. The study participants included those with
impaired fasting glucose and impaired glucose tolerance, as well as
normoglycaemia. The intervention model used in this study, de-
scribed in detail elsewhere [6], was based on the approach of the
Finnish GOAL study [14]. The program consisted of six two-hour
group sessions, the ﬁrst ﬁve over eight weeks and the last delivered
at 8 months. A goal setting and planning approach was used to en-
hance behaviour change in physical activity and dietary habits.
Regular self-assessment was used to empower participants to
make personal short and long term goals, and create structured
plans to achieve these. As in the Finnish study [10], ﬁve goals were
targeted with these aims: (1) less than 30 percent of the total en-
ergy intake from fat, (2) less than 10 percent of total energy intake
from saturated fat, (3) more than 15 g of ﬁbre/1000 calories, (4)
more than 4 h/week of moderate level physical activity and (5)
more than ﬁve percent weight reduction.311 pa
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Fig. 1. ParticipantsIn total, 311 individuals (88 men and 223 women) aged 40–
75 years were eligible to participate.2.2. Randomisation
According to facilitator records, 228 individuals were expected
to complete the GGT DPP and be willing to participate in the fol-
low-up. Participants within the session groups were pre-emptively
divided equally, randomised into a group receiving telephone sup-
port and a group without telephone support (self-care), with 11
married couples kept together to limit contamination. Inclusion
criteria for the follow-up required that participants complete the
GGT DPP and not have pre-existing T2DM.
As the end of the GGT DPP overlapped with the beginning of the
follow-up, participants expected to complete the GGT DPP were
not necessarily the same as those who actually completed the
GGT DPP. Of 311 individuals who began the original intervention,
237 attended both baseline and 12 month health checks and at
least one of the six sessions of the program (Fig. 1). After the initial
randomisation of 228 individuals, seventeen not completing the
GGT DPP and four diagnosed with T2DM at 12 months were
excluded. Another two who received the GGT DPP intervention de-
spite being outside the age limit were also excluded. The remaining
205 were allocated to telephone support (n = 107) and self-care
only (n = 98).2.3. Telephone support follow-up
The telephone support group received regular calls from spe-
cially trained nurses, mainly recruited from the original GGT DPP
[6], supervised by a clinical health psychologist with experience
in chronic disease management and T2DM intervention programs.
Calls followed a semi-structured interview. The questionnaire re-
ferred to by the nurses contained the personal goals (physical
activity and diet) that had been set at the end of the 12 month
intervention, and speciﬁc questions on achievement, compliance,
and difﬁculties encountered. Nurses recorded this information,
and gave advice and encouragement towards achieving and main-
taining these goals. If necessary, support materials were sent to
participants, or they were referred to a relevant support servicerticipants started the 
T DPP (baseline)
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pants were phoned 4 weeks after completing the initial 12 months
GGT DPP, monthly for the next 5 months, and bi-monthly for the
subsequent 12 months (maximum of 12 phone calls). Calls were
expected to last approximately 15 min, depending on the support
required. The self-care groups were not contacted by study nurses
during the follow-up until being invited to attend the 30 month
clinical tests.
2.4. Measurements
Clinical measurements including height, weight, waist and hip
circumference, and blood pressure measurements, were made by
study nurses at the end of the 12 month main intervention, as pre-
viously described [6], and the end of the 30 months. Participants
fasted overnight for a minimum of 8 h before the blood tests. Fast-
ing plasma glucose (FPG), 2 h oral glucose tolerance test (2 h-
OGTT), total cholesterol, triglycerides and high density lipoprotein
(HDL) cholesterol were analysed [6]. Use of lipid and blood pres-
sure lowering medication was also recorded.
In addition, participants were assessed for psychological dis-
tress (Kessler 10 Psychological Distress Scale) [15] and depression
(Hospital Anxiety and Depression Scale (HADS)) [16]. General
health was assessed using the Short Form 36 (SF-36v2) [17] stand-
ardised to Australian population norms [18].
2.5. Statistical analyses
Statistical analyses were performed using PASW Statistics
(SPSS) Version 17. Percentages, means, standard errors (SE), and
95% conﬁdence intervals are presented. To test differences be-
tween telephone support and self-care only groups, t-tests and
chi-square tests were performed (Table 1). Analysis of covarianceTable 1
Mean (SE) difference between self-care participants (n = 79) and telephone support pa
psychosocial).
Self-care (n = 79) T
Baseline
Gender (% male) n = 27 (34.2%) n
Age (years) 56.5 (0.9) 5
Education (years) 12.2 (0.4) 1
Beginning of telephone support
Systolic blood pressure (mmHg) 130.6 (1.7) 1
Diastolic blood pressure (mmHg) 79.0 (1.0) 7
Weight (kg) 89.7 (2.2) 8
BMI (kg/m2) 32.1 (0.6) 3
Waist circumference (cm) 100.0 (1.7) 1
Hip circumference (cm) 111.8 (1.4) 1
2 h-OGTT (mmol/L) 6.03 (0.18) 5
FPG (mmol/L) 5.37 (0.06) 5
Total cholesterol (mmol/L) 5.42 (0.13) 5
Triglycerides (mmol/L) 1.85 (0.11) 1
HDL-cholesterol (mmol/L) 1.38 (0.04) 1
LDL-cholesterol (mmol/L) 3.23 (0.12) 3
K-10 score 14.6 (0.8) 1
HADS depression score 2.22 (0.36) 2
SF-36 v2
Physical functioning 49.0 (1.0) 4
Role limitations physical 48.4 (1.1) 4
Bodily pain 46.8 (1.3) 4
General health 50.5 (0.9) 5
Vitality 51.1 (1.0) 5
Social functioning 48.5 (1.2) 4
Role limitation emotional 46.2 (1.5) 4
Mental health 49.3 (1.1) 4
Physical component summary 49.1 (1.0) 4
Mental component summary 48.6 (1.3) 4was used to adjust for gender differences between 12 and
30 months (Table 2). To assess long term effects, all participants
completing the original 12 month GGT DPP and attending
30 month clinical tests were included in intention-to-treat analy-
ses. Men and women were analysed separately. Since no gender
differences were found, results are presented for the combined
sample (Table 3). Each analysis consisted of all available data, with
a maximum of 9.9% missing (for mental component summary, Ta-
ble 3).
2.6. Ethics
Participants gave written consent. The study was approved by
the Flinders University Clinical Research Ethics Committee (refer-
ence number 105/034) and registered as a clinical trial
(ISRCTN38031372).
3. Results
Of 205 eligible participants, 164 completed the follow-up. Of
these, 85 received telephone support (mean 6.6 calls, SD = 2.8,
mean length of call 20 min) and 79 had self-care information only
(Fig. 1). The self-care group had slightly more men than the tele-
phone support group but otherwise the groups were well matched
(Table 1).
Changes in outcome measures between 12 and 30 months are
shown separately for the telephone support and self-care groups
in Table 2. Between group differences were not signiﬁcant. Since
the telephone support did not appear to impact on the outcome
measures, this allowed the two groups to be combined for further
analyses. In order to assess the longer term effects of the GGT DPP,
all available data was utilised. This included four participants who
had diagnosed T2DM at 12 months, and four who had prematurelyrticipants (n = 85) at baseline (demographics) and 12 months (anthropometric and
elephone support (n = 85) Difference p-value
= 19 (22.4%) 11.82% 0.092
7.1 (1.0) 0.59 (1.35) 0.662
1.8 (0.5) 0.40 (0.51) 0.434
29.5 (1.7) 1.06 (2.44) 0.664
8.0 (1.1) 1.02 (1.51) 0.498
8.5 (1.8) 1.15 (2.80) 0.683
2.6 (0.7) 0.45 (0.96) 0.641
00.3 (1.3) 0.29 (2.10) 0.889
13.7 (1.4) 1.92 (2.03) 0.346
.89 (0.16) 0.14 (0.24) 0.552
.29 (0.06) 0.08 (0.08) 0.337
.35 (0.10) 0.08 (0.17) 0.648
.79 (0.13) 0.06 (0.17) 0.719
.46 (0.05) 0.07 (0.06) 0.262
.11 (0.10) 0.12 (0.15) 0.435
4.3 (0.4) 0.27 (0.89) 0.759
.39 (0.28) 0.17 (0.45) 0.709
8.5 (1.0) 0.46 (1.39) 0.743
7.7 (0.9) 0.72 (1.42) 0.615
5.1 (1.2) 1.72 (1.76) 0.331
0.6 (0.7) 0.05 (1.15) 0.969
0.2 (0.8) 0.91 (1.27) 0.471
9.3 (0.9) 0.84 (1.52) 0.579
7.2 (1.2) 0.99 (1.88) 0.599
8.7 (0.9) 0.60 (1.44) 0.679
8.1 (1.0) 0.97 (1.36) 0.477
9.0 (1.0) 0.40 (1.64) 0.810
Table 2
Mean (SE) changes in self-care and telephone support groups from 12 to 30 months.
Self-care (n = 79) Telephone support (n = 85) Difference p-value
Systolic blood pressure (mmHg) 2.25 (1.73) 1.94 (1.54) 0.31 (2.31) 0.433
Diastolic blood pressure (mmHg) 0.03 (1.31) 0.26 (0.96) 0.29 (1.61) 0.865
Weight (kg) 1.12 (0.53) 1.13 (0.50) 0.01 (0.73) 0.949
BMI (kg/m2) 0.43 (0.19) 0.40 (0.19) 0.02 (0.27) 0.988
Waist circumference (cm) 0.32 (0.60) 0.90 (0.63) 1.21 (0.87) 0.419
Hip circumference (cm) 0.64 (0.52) 0.63 (0.50) 0.00 (0.72) 0.951
2 h-OGTT (mmol/L) 0.11 (0.22) 0.31 (0.19) 0.20 (0.29) 0.387
FPG (mmol/L) 0.38 (0.05) 0.41 (0.05) 0.03 (0.07) 0.780
Total cholesterol (mmol/L) 0.22 (0.12) 0.15 (0.09) 0.07 (0.15) 0.779
Triglycerides (mmol/L) 0.18 (0.09) 0.19 (0.07) 0.01 (0.11) 0.801
HDL-cholesterol (mmol/L) 0.00 (0.02) 0.03 (0.02) 0.03 (0.03) 0.255
LDL-cholesterol (mmol/L) 0.12 (0.11) 0.02 (0.08) 0.09 (0.13) 0.883
K-10 score 0.10 (0.47) 0.11 (0.57) 0.02 (0.75) 0.924
HADS depression score 0.65 (0.29) 0.15 (0.29) 0.50 (0.41) 0.152
SF-36 v2
Physical functioning 1.29 (0.82) 0.34 (0.66) 0.95 (1.04) 0.311
Role limitations physical 0.20 (0.98) 0.09 (0.82) 0.29 (1.28) 0.748
Bodily pain 1.17 (1.02) 0.18 (1.04) 0.99 (1.46) 0.549
General health 1.37 (0.64) 0.59 (0.65) 0.78 (0.92) 0.515
Vitality 1.00 (0.80) 0.73 (0.94) 0.28 (1.25) 0.913
Social functioning 0.66 (1.19) 0.98 (1.08) 1.64 (1.60) 0.644
Role limitations emotional 0.06 (1.42) 1.43 (1.18) 1.49 (1.84) 0.649
Mental health 0.36 (1.05) 0.33 (1.12) 0.03 (1.53) 0.959
Physical component summary 1.23 (0.89) 0.05 (0.73) 1.29 (1.15) 0.245
Mental component summary 0.27 (1.23) 1.09 (1.21) 1.36 (1.73) 0.704
Table 3
Comparison of means (SE) at baseline, 12 and 30 months and mean changes (95% CI) between baseline and 12, 12 and 30 months and baseline and 30 months (n = 172).
0 months 12 months 30 months Changes 0–12 Changes 12–30 Changes 0–30
Systolic blood pressure (mmHg) 131.3 (1.3) 130.3 (1.2) 132.0 (1.2) 0.97 (2.95, 1.01) 1.68 (0.55, 3.91) 0.71 (1.67, 3.10)
Diastolic blood pressure (mmHg) 80.7 (0.8) 78.5 (0.7) 78.7 (0.8) 2.23 (3.69, 0.77)* 0.23 (1.30, 1.77) 1.99 (3.55, 0.44)*
Weight (kg) 92.0 (1.4) 89.3 (1.4) 90.3 (1.4) 2.68 (3.52, 1.85)* 1.03 (0.33, 1.73)* 1.65 (2.51, 0.79)*
BMI (kg/m2) 33.3 (0.5) 32.4 (0.5) 32.7 (0.5) 0.98 (1.28, 0.68)* 0.38 (0.12, 0.64)* 0.60 (0.91, 0.28)*
Waist circumference (cm) 104.5 (1.0) 100.5 (1.0) 100.4 (1.1) 3.95 (4.74, 3.16)* 0.18 (1.03, 0.66) 4.13 (5.05, 3.21)*
Hip circumference (cm) 115.4 (1.0) 112.8 (1.0) 113.4 (1.0) 2.62 (3.31, 1.93)* 0.63 (0.07, 1.32) 2.00 (2.79, 1.20)*
2 h-OGTT 6.66 (0.13) 6.01 (0.13) 6.27 (0.17) 0.65 (0.90, 0.39)* 0.26 (0.02, 0.54) 0.39 (0.69, 0.08)*
FPG 5.51 (0.04) 5.35 (0.04) 5.75 (0.04) 0.15 (0.22, 0.08)* 0.39 (0.32, 0.47)* 0.24 (0.17, 0.31)*
Total cholesterol 5.64 (0.08) 5.39 (0.08) 5.22 (0.07) 0.25 (0.38, 0.13)* 0.17 (0.31, 0.03)* 0.42 (0.57, 0.27)*
Triglycerides 1.94 (0.08) 1.80 (0.08) 1.63 (0.07) 0.14 (0.26, 0.03)* 0.18 (0.28, 0.07)* 0.32 (0.44, 0.20)*
HDL-cholesterol 1.35 (0.03) 1.42 (0.03) 1.40 (0.03) 0.07 (0.03, 0.10)* 0.02 (0.05, 0.01) 0.05 (0.01, 0.08)*
LDL-cholesterol 3.41 (0.08) 3.17 (0.08) 3.12 (0.07) 0.25 (0.36, 0.14)* 0.05 (0.18, 0.08) 0.30 (0.42, 0.17)*
K-10 score 15.0 (0.4) 14.2 (0.4) 14.3 (0.5) 0.76 (1.36, 0.16)* 0.09 (0.62, 0.81) 0.66 (1.40, 0.07)
HADS depression score 2.82 (0.23) 2.33 (0.23) 2.77 (0.25) 0.49 (0.87, 0.10)* 0.44 (0.04, 0.83)* 0.05 (0.43, 0.33)
SF-36 v2
Physical functioning 47.9 (0.6) 48.7 (0.7) 48.1 (0.7) 0.84 (0.23, 1.91) 0.68 (1.69, 0.32) 0.16 (0.99, 1.31)
Role limitations physical 47.6 (0.7) 47.9 (0.7) 47.9 (0.7) 0.30 (1.12, 1.72) 0.00 (1.25, 1.25) 0.30 (1.20, 1.80)
Bodily pain 43.4 (0.9) 46.2 (0.9) 45.4 (0.9) 2.81 (1.13, 4.49)* 0.86 (2.27,0.55) 1.95 (0.22, 3.68)*
General health 47.6 (0.6) 50.2 (0.6) 49.5 (0.6) 2.57 (1.59, 3.56)* 0.72 (1.58, 0.14) 1.85 (0.82, 2.88)*
Vitality 47.7 (0.7) 50.7 (0.6) 49.7 (0.7) 3.01 (1.84, 4.18)* 0.95 (2.12, 0.23) 2.06 (0.74, 3.38)*
Social functioning 49.1 (0.7) 48.6 (0.8) 48.4 (0.8) 0.41 (1.87, 1.05) 0.24 (1.75, 1.27) 0.65 (2.04, 0.74)
Role limitations emotional 46.7 (1.0) 46.6 (1.0) 46.1 (1.0) 0.12 (2.21, 1.98) 0.53 (2.26, 1.20) 0.65 (2.50, 1.20)
Mental health 47.1 (0.8) 49.0 (0.7) 48.6 (0.8) 1.97 (0.65, 3.30)* 0.45 (1.90, 0.99) 1.52 (0.02, 3.06)
Physical component summary 46.9 (0.7) 48.7 (0.7) 48.0 (0.7) 1.75 (0.60, 2.89)* 0.63 (1.77, 0.50) 1.11 (0.22, 2.45)
Mental component summary 47.5 (0.9) 48.4 (0.9) 48.0 (0.9) 0.89 (0.70, 2.48) 0.34 (2.01, 1.34) 0.55 (1.05, 2.15)
* p < 0.05.
98 J.A. Dunbar et al. / International Journal of Diabetes Mellitus 2 (2010) 95–100been considered as ‘dropped-out’ of the GGT DPP and therefore not
been randomised.
Among the 172 participants who completed the 12 month DPP
intervention and attended the 30 month clinical tests, improve-
ments in anthropometric, blood pressure, and lipid variables
apparent at 12 months were generally maintained at 30 months
with some exceptions (Table 3).
Although weight increased by 1.03 kg during the follow-up per-
iod (12–30 months) there was still a 30 month mean reduction of
1.65 kg. Waist circumference decreased further during the fol-
low-up and after 30 months there was a mean reduction of4.13 cm. Decrease in 2 h-OGTT during the ﬁrst 12 months attenu-
ated during follow-up, but at 30 months was still signiﬁcantly bet-
ter (0.39 mmol/L) than baseline. In contrast, FPG, which improved
during the original 12 month study, increased during follow-up,
and was 0.24 mmol/L higher at 30 months than baseline.
Triglycerides and total cholesterol showed further improve-
ment. This resulted in overall reductions of 0.32 and 0.42 mmol/
L, respectively.
After commencement of the initial 12 month intervention, 12
participants started medication for dyslipidemia (n = 5 during the
GGT DPP and n = 7 during the follow-up) and 10 for hypertension
J.A. Dunbar et al. / International Journal of Diabetes Mellitus 2 (2010) 95–100 99(n = 2 during the GGT DPP and n = 8 during the follow-up). When
these are excluded, there is a slight increase in systolic blood pres-
sure during follow-up. Also the further reduction between 12 and
30 months in total cholesterol was no longer evident.
The impact on psychological measures was mixed. Depression
scores improved during the initial 12 month intervention but
subsequently regressed to baseline. Also the statistically signiﬁcant
effect on psychological distress diminished during follow-up so
that at the end the effect was no longer statistically signiﬁcant. Po-
sitive effects observed on bodily pain, general health and vitality
were maintained during follow-up. Mental health and physical
composite scores regressed toward baseline. All other measures
of health were unchanged during the follow-up.
Of the 237 participants who completed the original GGT DPP, a
comparison between 30 month clinical test attendees (n = 172)
and non-attendees (n = 65) was undertaken. At beginning of fol-
low-up (i.e. 12 months after commencing initial intervention) no
differences were found in demographics, anthropometric or clini-
cal measurements, but non-attendees had worse physical func-
tioning at 12 months when compared with attendees (data not
shown).4. Discussion
The present study suggests that gains achieved at 12 months
during the GGT DPP [6], in a primary health care setting, can be
sustained over the following 18 months. Telephone support did
not signiﬁcantly improve the sustainability of the original inter-
vention. Our results will inform further studies investigating the
best ways to provide ongoing support to participants, which re-
mains an important focus for those conducting diabetes prevention
programs.
The success of the main intervention relied on the theories of
behaviour change that were used. The theoretical framework of
this intervention was based on the Health Action Process Approach
(HAPA) [19] and on self-regulation theory [20]. The HAPA
model incorporates a two-stage model with distinct phases for
motivation formation and action. Alongside the HAPA model,
self-regulation theory helps participants formulate goals and ﬁnd
strategies to achieve these goals through the difﬁcult process of
planning preparation and initiation of intended behaviour change
action [21].
Participants involved in the 12 month intervention were guided
to plan how they would start achieving their behaviour changes.
They were encouraged to incorporate the basic principles and
appropriate skills into daily life in order to choose and plan con-
crete, positive, attainable and evolving goals that could be sus-
tained and achieved in the long term. Participants set personal
goals such as ‘eat more fruit and vegetables’, ‘have healthier snacks
ready’ or ‘walk around the block with the dog’.
When participants agreed to continue the study with or without
18 month telephone support follow-up, they were able to:
acknowledge that they were at risk of type 2 diabetes, learn that
the disease can be prevented by lifestyle changes, gain conﬁdence
in their ability to change, decide to change, plan where, when and
how to make changes, learn how to avoid barriers and use re-
sources, and learn how to recover from relapses.
Prevention programs demonstrate substantial beneﬁts of
healthy lifestyle changes in reducing risk of developing T2DM
[10,22–24]. The GGT DPP lifestyle intervention study achieved re-
sults comparable with earlier clinical trials [23–25]. For successful
chronic disease programs, sustained effects are of major interest.
Someweight loss and smoking cessation programs have shown loss
of beneﬁts in the long term, such as regaining weight, sometimes
higher [26] than the initial weight, or reversion to smoking [27].In the present study, outcomes of particular interest included
physical (weight, waist and hip circumference, and blood pressure)
and biochemical (total, LDL- and HDL-cholesterol, triglycerides,
FPG, and 2 h-OGTT) measurements at 30 months. Almost all
improvements shown at 12 months were sustained at 30 months
with the main exception of FPG. Although weight increased during
follow-up, overall it remained signiﬁcantly lower than baseline,
and reduction in waist circumference was maintained. The reduc-
tion in waist circumference is of major importance because central
adiposity is the main driver of metabolic abnormalities that lead to
type 2 diabetes [28]. Improvements in diastolic blood pressure and
lipids, especially triglycerides, were maintained.
Fasting and 2 h glucose were lower at 12 months than at base-
line, both rebounding by 30 months, especially fasting glucose.
This observation in those at high risk of diabetes parallels ﬁndings
in the United Kingdom Prospective Diabetes Study (UKPDS) [29].
Those treated for established T2DM (usually with medication) ini-
tially had improved glycaemic control, but declined progressively
over time. The effect is much like setting the clock back and slow-
ing the progression of the beta islet cell failure.
No signiﬁcant differences in mean outcome measures were
found between the groups, with and without telephone support.
As an extension of the GGT DPP, telephone counseling aimed pri-
marily at supporting participants in sustaining the beneﬁts already
achieved, rather than to facilitate further improvement. Addition-
ally, the self-care group showed continuing beneﬁts of the original
12 month intervention. Consequently, it is likely that our sample
size was not large enough to determine the true effect of the tele-
phone support.
During telephone support calls, enablers and barriers were dis-
cussed with participants, and actions taken such as referral to GP
or counselor when needed. In general, the nurses reported a lack
of new issues to discuss with participants. Although 12 telephone
calls were scheduled, participants received an average of 6.6 calls.
Some of those allocated to telephone support declined calls
(n = 16). Excluding these individuals had minimal effect on results
(data not shown). For others, length of calls decreased over time,
and participants who received more calls tended to have worse
mental health and cholesterol, and better physical functioning.
Telephone support could not have alleviated physical problems,
and it is likely that those who had already been successful in their
lifestyle changes did not ﬁnd much beneﬁt in support. Others may
have struggled with meeting their goals and accepted more calls,
but required more than was offered by the telephone support. The
social support offered by the telephone calls may have also been a
substitute for support obtained in the GGT DPP group sessions.
Email was considered as an alternative to telephone communi-
cation. However, this appeared less appropriate with an older age
group from a rural area, with poor access to the internet, and pref-
erence for more personalised verbal communication.
Whilst evidence supporting efﬁcacy of the telephone as a pri-
mary intervention method to deliver physical activity and dietary
behaviour change interventions is promising, effects on outcomes
measured have been mainly short-term with very few signiﬁcant
reductions reported for body mass index (BMI), lipids or blood
pressure [12]. Additionally, studies on its use in diabetes manage-
ment have not demonstrated effectiveness for sustaining lifestyle
changes post-intervention [30].
The major strength of this study is that it has been successfully
implemented within a primary care setting and reports sustain-
ability of a group-based diabetes prevention program over
18 months of follow-up. There were some dropouts. However,
these individuals were similar at 12 months to those attending
30 month clinical testing. Also, in a small community, the likeli-
hood of cross-contamination is increased, and we have no informa-
tion regarding further contact between the participants.
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In conclusion, this group-based prevention program in a pri-
mary health care setting, for individuals at high risk of T2DM, re-
sults in good initial outcomes which are sustained at 30 months.
Although providing telephone support on completion of the initial
12 month intervention did not appear to produce additional bene-
ﬁts, further investigations into optimising ongoing support for
these individuals remains an important issue.Conﬂict of interest
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